Description

Pre-blended vial containing CJC-1295 (no DAC), a modified GRF(1-29) analogue, and Ipamorelin, a selective ghrelin receptor pentapeptide agonist. The two compounds are widely co-investigated in pulsatile growth hormone release research, where the GHRH analogue and GHRP are studied for their complementary mechanisms at the somatotroph. Lyophilised powder, third-party tested.